DE602005018739D1 - Phosphorylierte SP1 als Marker bei der Diagnose nieim Drogenscreening auf NASH - Google Patents

Phosphorylierte SP1 als Marker bei der Diagnose nieim Drogenscreening auf NASH

Info

Publication number
DE602005018739D1
DE602005018739D1 DE602005018739T DE602005018739T DE602005018739D1 DE 602005018739 D1 DE602005018739 D1 DE 602005018739D1 DE 602005018739 T DE602005018739 T DE 602005018739T DE 602005018739 T DE602005018739 T DE 602005018739T DE 602005018739 D1 DE602005018739 D1 DE 602005018739D1
Authority
DE
Germany
Prior art keywords
nash
phosphorylated
marker
diagnosis
never
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005018739T
Other languages
English (en)
Inventor
De La Paz Jose Maria Mato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
One Way Liver Genomics SL
Original Assignee
One Way Liver Genomics SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One Way Liver Genomics SL filed Critical One Way Liver Genomics SL
Publication of DE602005018739D1 publication Critical patent/DE602005018739D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005018739T 2005-03-11 2005-10-11 Phosphorylierte SP1 als Marker bei der Diagnose nieim Drogenscreening auf NASH Active DE602005018739D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05075602 2005-03-11

Publications (1)

Publication Number Publication Date
DE602005018739D1 true DE602005018739D1 (de) 2010-02-25

Family

ID=36971474

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018739T Active DE602005018739D1 (de) 2005-03-11 2005-10-11 Phosphorylierte SP1 als Marker bei der Diagnose nieim Drogenscreening auf NASH

Country Status (4)

Country Link
US (1) US7632649B2 (de)
AT (1) ATE454631T1 (de)
DE (1) DE602005018739D1 (de)
ES (1) ES2339125T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4682980B2 (ja) * 2004-04-23 2011-05-11 味の素株式会社 非アルコール性脂肪肝炎鑑別方法
EP2157431A1 (de) * 2008-08-11 2010-02-24 One Way Liver Genomics, S.L. Verfahren zur NASH-Diagnose unter Verwendung von Stoffwechselprofilen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084072A (en) * 1990-04-11 2000-07-04 The Regents Of The University Of Michigan Purified lectin and methods of use
US5854254A (en) * 1994-03-30 1998-12-29 North Shore University Hospital Male contraceptives
US20020137715A1 (en) 2001-01-03 2002-09-26 Alain Mauviel Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes

Also Published As

Publication number Publication date
US7632649B2 (en) 2009-12-15
ATE454631T1 (de) 2010-01-15
ES2339125T3 (es) 2010-05-17
US20060205023A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
MA31231B1 (fr) Anticorps anti-robo4 et utilisations de ceux-ci
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
DK1874818T3 (da) TGF-Beta 1-specifikke antistoffer
DE502007004174D1 (de) Markerkomposit für medizinische Implantate
DE502006000512D1 (de) Tastenventil für medizinische Instrumente
NO20071880L (no) Diagnostic Compounds
WO2007112193A3 (en) Camptothecin-binding moiety conjugates
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
UY30979A1 (es) Pirrolidinamidas sustituidas, su preparacion y su uso como medicamentos
EA200802210A1 (ru) Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств
DE602006019128D1 (de) Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs
DE602006005739D1 (de) Medizinische Vorrichtung
DK2026803T3 (da) Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
CY1115212T1 (el) Διαμεσολαβηση στην κυτταροτοξικοτητα των κυτταρων που παρουσιαζουν eπιφaneiakh εκφραση της cd44
MX2010001247A (es) Agentes de imagenologia optica.
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
DE602006013109D1 (de) Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
EA200900261A1 (ru) Применение эсцина
ATE513677T1 (de) Medizinische vorrichtungen sowie entsprechende systeme und verfahren
DK2099461T3 (da) LNA Nukleoside Phosphoramidates
DE502007005857D1 (de) Isoliertes naturidentisches kollagen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition